FCGR2A and cancer: Previous studies comparing the CD3ζ intracellular domains, commonly used in CAR T cells with the FcγR signaling domain have demonstrated that both can trigger phagocytosis of cancer cells with similar efficiency in macrophages derived from THP-1 cells [46], HSPC [46] and iPSCs [17, 47].